Search

everythinglearnresearchcommunity

for

Search:↓

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Boosting mitochondrial energy production with supplements like acetyl-L-carnitine may improve aging-related cellular function and health conditions.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Sunscreen use may increase the risk of frontal fibrosing alopecia.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Caffeine can protect scalp hair follicles from damage caused by UV radiation.

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Patients with SLE experienced non-scarring hair loss with fewer hair follicles, and DIF did not help identify lupus.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Future acne treatments should aggressively target inflammation to prevent scarring.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Hair loss in black women needs more research, early intervention, and community education.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The document concludes that stopping shaving or removing affected hair can alleviate Pseudofolliculitis barbae (PFB).

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.

Home-use medical-cosmetic devices like lasers for hair removal may be convenient but need more research to confirm safety and effectiveness.